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Acute Myocardial Infarction
Myeloperoxidase Levels Predict Post-MI Mortality
Myeloperoxidase (MPO) is an enzyme released from neutrophils that lead to thegeneration of free radicals and reactive nitrogen species. Recent studies have
shown that it predicts poor outcomes in patients presenting with chest pain or acute
coronary syndromes. Mocatta and colleagues studied its utility in risk stratifying 500
acute myocardial infarction (MI) patients 24 to 96 h after their infarction. Myeloper-
oxidase was found to be elevated in post-MI patients compared to healthy controls.
Furthermore, highMPOlevelswere independently predictive of subsequentmortality,
adding prognostic information to both brain natriuretic peptide levels and ejection
fraction. This study confirms that an elevated MPO is a poor prognostic predictor.
See page 1993. See figure.
Page 2007
Coronary Artery Disease
Lowering LDL, Not Pleiotropic Effects, Reduces CRP
Whereas statins are known to have anti-inflammatory effects, other studiessuggest that any method of low-density lipoprotein (LDL) lowering reduces
inflammatory markers. Kinlay performed a meta-analysis of 23 placebo-controlled,
randomized studies that reported efficacy for both LDL reduction and change in
C-reactive protein (CRP). Meta-regression analysis showed a strong correlation be-
tween the change in LDL and the change in CRP; statin therapies had no significant
independent effect on CRP after adjusting for the change in LDL. This study suggests
that the efficacy of statins in reducing CRP levels relates to their efficiency at lowering
LDL rather than to the other metabolic pathways affected by statins. See page
2003. See figure.
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Heart Failure
Central Sleep Apnea Doubles Mortality Risk for Those With LV Dysfunction
There has been conflicting evidence regarding the significance of sleep apnea as acardiac risk factor. Javaheri and colleagues followed 88patientswith systolic heart
failure (ejection fraction 45%), including sophisticated studies to diagnose and
characterize central sleep apnea (CSA). The median survival of patients without CSA
was twice as long as those with CSA: 90 versus 45 months. This study confirms that
CSA is an independent risk factor for poor outcomes in patients with systolic heart
failure. See page 2028. See figure.
(continued) A-30Heart Rhythm Disorders
Characterizing Ventricular Outflow Tract Arrhythmias
Kim and colleagues sought to compare and contrast several characteristics ofidiopathic outflow tract arrhythmias. Over 100 patients with either: 1) paroxys-
mal sustained monomorphic ventricular tachycardia (SMVT); 2) repetitive nonsus-
tained ventricular tachycardia (NSVT); or 3) premature ventricular contractions
(PVCs) underwent electrophysiologic studies. The sites of origin of the arrhythmias
were similar among the 3 groups, with over 80% originating in the right ventricular
outflow tract. Sustained VT was inducible during electrophysiologic study in 78% of
SMVT patients, 48% of NSVT patients, and 4% of PVC patients. This finding
suggests that rather than representing distinct entities, outflow arrhythmias may be
considered a continuumof a singlemechanismwithdifferent presentations.Seepage
2035.
Cardiac Imaging
MDCT Can Be Used to Differentiate Idiopathic Versus Ischemic
Cardiomyopathies
Andreini and colleagues performed 16-slice multidetector computed tomography(MDCT) in 61 patients with a newly diagnosed dilated cardiomyopathy (DCM)
in order to determine if MDCT can reliably distinguish ischemic from nonischemic
cardiomyopathies.All patients subsequentlyunderwent conventional coronary angiog-
raphy. There were no procedural complications with MDCT, whereas there were 10
complications during or after angiography. Multidetector CT correctly stratified all
patients with normal or pathological coronary arteries. In conclusion, MDCT is safe
and accurate for distinguishing idiopathic versus ischemicDCMandmay invoke fewer
complications. See page 2044.
